290 related articles for article (PubMed ID: 12843916)
1. [Screening for hepatocellular carcinoma: between cynicism or perfectionism?].
Hadengue A
Gastroenterol Clin Biol; 2003 May; 27(5):525-7. PubMed ID: 12843916
[No Abstract] [Full Text] [Related]
2. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
3. [Screening for hepatocarcinoma in a cohort with cirrhosis mainly of alcoholic origin].
Henrion J; Libon E; De Maeght S; Deltenre P; Schapira M; Ghilain JM; Maisin JM; Heller FR
Gastroenterol Clin Biol; 2003 May; 27(5):534-9. PubMed ID: 12843918
[TBL] [Abstract][Full Text] [Related]
4. [Hepatocellular carcinoma--an increasing problem in the Western world].
Wiedermann KH
MMW Fortschr Med; 2009 Apr; 151(15):40-3. PubMed ID: 19728682
[No Abstract] [Full Text] [Related]
5. Hepatocellular carcinoma: status in the era of liver transplantation.
Singhal A; Jabbour N
J Okla State Med Assoc; 2009 Dec; 102(12):355-61. PubMed ID: 20131731
[No Abstract] [Full Text] [Related]
6. [Mass screening for high risk group of hepatocellular carcinoma].
Kawanishi T; Mima S
Nihon Rinsho; 2001 Oct; 59 Suppl 6():786-90. PubMed ID: 11762057
[No Abstract] [Full Text] [Related]
7. Detection of hepatocellular cancer during screening of 1125 patients with chronic hepatitis virus infection.
Izzo F; Cremona F; Ruffolo F; Palaia R; Parisi V; Curley S
J Chemother; 1997 Apr; 9(2):151-2. PubMed ID: 9176768
[No Abstract] [Full Text] [Related]
8. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
9. [Hepatic carcinogenesis: prevalent role of hepatitis C virus?].
Oberti F
Gastroenterol Clin Biol; 1994; 18(4):394-6. PubMed ID: 7958666
[No Abstract] [Full Text] [Related]
10. [Hepatocellular carcinoma].
Lemoine A; Azoulay D; Jezequel-Cuer M; Debuire B
Pathol Biol (Paris); 1999 Nov; 47(9):903-10. PubMed ID: 10609270
[TBL] [Abstract][Full Text] [Related]
11. [High risk group for development of hepatocellular carcinoma].
Koike Y; Shiratori Y
Nihon Rinsho; 2001 Oct; 59 Suppl 6():362-6. PubMed ID: 11761973
[No Abstract] [Full Text] [Related]
12. [Informed consent for high risk group of hepatocellular carcinoma].
Yamada G
Nihon Rinsho; 2001 Oct; 59 Suppl 6():812-6. PubMed ID: 11762062
[No Abstract] [Full Text] [Related]
13. [Alcohol and hepatitis C virus: the return of hepatotropic viruses].
Nalpas B
Gastroenterol Clin Biol; 1994; 18(2):105-9. PubMed ID: 8013791
[No Abstract] [Full Text] [Related]
14. [Significance of medical examination for HCV infection as a national project for prevention of hepatocellular carcinoma in Japan].
Katayama K; Tanaka J; Komiya Y; Kumagai J; Yoshizawa H
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):248-52. PubMed ID: 15359801
[No Abstract] [Full Text] [Related]
15. [Risk factors and prevention of hepatocellular carcinoma].
Tanaka K
Fukuoka Igaku Zasshi; 1997 Oct; 88(10):325-30. PubMed ID: 9432489
[No Abstract] [Full Text] [Related]
16. Hepatocellular carcinoma. New directions in etiology.
Maltz C; Lightdale CJ; Winawer SJ
Am J Gastroenterol; 1980 Oct; 74(4):361-5. PubMed ID: 6161536
[No Abstract] [Full Text] [Related]
17. [Screening for hepatocellular carcinoma].
Leone N; Rizzetto M
Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
[TBL] [Abstract][Full Text] [Related]
18. [High risk group and screening methods of hepatocellular carcinoma].
Matsushita E; Kaneko S; Kobayashi K
Nihon Rinsho; 2001 Oct; 59 Suppl 6():229-35. PubMed ID: 11761945
[No Abstract] [Full Text] [Related]
19. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
El-Aneed A; Banoub J
Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
[TBL] [Abstract][Full Text] [Related]
20. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma.
Hayashi PH; Di Bisceglie AM
Med Clin North Am; 2005 Mar; 89(2):345-69. PubMed ID: 15656930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
